ArticleDiabetes research and clinical practice2026
Association of GLP-1 receptor agonists, SGLT 2 inhibitors, DPP-4 inhibitors, and sulfonylureas with incident cancer in type 2 diabetes.
Stacey M Sklepinski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.